Fortescue Ltd
FMG
Woodside Energy Group Ltd
WDS
Origin Energy Ltd
ORG
Telstra Group Ltd
TLS
BHP Group Ltd
BHP
AU Stock MarketDetailed Quotes
ACW Actinogen Medical Ltd
- 0.025
- 0.0000.00%
20min DelayMarket Closed Dec 20 16:00 AET
78.32MMarket Cap-4.17P/E (Static)
0.025High0.024Low2.15MVolume0.025Open0.025Pre Close53.33KTurnover0.09952wk High0.09%Turnover Ratio3.13BShares0.02052wk Low-0.006EPS TTM57.29MFloat Cap1.777Historical HighLossP/E (Static)2.29BShs Float0.007Historical Low-0.006EPS LYR4.00%Amplitude--Dividend TTM4.17P/B1Lot Size--Div YieldTTM
Actinogen Medical Ltd News
Actinogen Medical Doses First Participant in Alzheimer's Disease Trial in US; Shares Rise Nearly 7%
This Biotech Stock Raised $11M in a Risk-off Environment. Its Alzheimer's Drug Could Change the Game
Actinogen Receives $9M R&D Tax Rebate to Fund Alzheimer's Trial
Actinogen Medical Ltd: Actinogen receives $9.0 million R&D tax incentive rebate
Actinogen Medical Ltd: Annual Report to Shareholders
Actinogen Medical Completes AU$8.1 Million Placement, Launches AU$3 Million Share Purchase Plan; Shares Fall 9%
Why Actinogen Medical, Flight Centre, JB Hi-Fi, and NextDC Shares Are Falling Today
Actinogen Medical Ltd: ACW FY2024 results, advancing into late-stage trials
Actinogen Medical Ltd: ACW Appendix 4E and 2024 Annual Report
Actinogen Medical (ASX:ACW) Shareholder Returns Have Been Enviable, Earning 506% in 5 Years
Actinogen Says Novel Antidepressant Xanamem Shows Significant Improvements on Four Week 10mg Daily Dose
Why Actinogen, ASX, Burgundy Diamond, and Lifestyle Communities Shares Are Sinking Today
Why Actinogen, Aurizon, Beach Energy, and PYC Shares Are Sinking Today
Why Is This ASX Healthcare Stock Crashing 67% on Monday?
Actinogen Medical Expects Results From XanaCIDD Phase 2a Clinical Trial in August; Shares Down 6%
Actinogen's Xanamem Could Slow Alzheimer's Progress, New Biomarker Trial Reveals
Actinogen Medical Completes AU$3.9 Million Non-Renounceable Entitlement Offer
Actinogen Medical Opens AU$3.9 Million Entitlement Offer; Shares Down 7%
Actinogen Medical Lodges Prospectus for Nearly AU$4 Million Entitlement Offer
Actinogen Medical Raising Up to AU$8.9 Million for Advancing Trial, Working Capital; Shares Fall 24%